Jieyang People's Hospital
1 clinical trials · Sponsor
◉ Watch Jieyang People's Hospital
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy (NCT06926985) | Jieyang People's Hospital | 2025-07-30 |
Track Jieyang People's Hospital automatically
Every clearance here is in the API, with alerts when new ones post.